MGAT3 and Alzheimer disease: Considering that Mgat3−/− mice show almost no phenotypic abnormality in terms of development, reproduction, hematology, and brain morphology (Orr et al, 2013; Priatel et al, 1997), our results highlight the possibility of a novel strategy for developing glycosyltransferase-targeted AD therapeutics.